Vaccines & Disease · Smallpox & Mpox

Smallpox & Monkeypox (Mpox) Disease & Vaccine Information

Below are brief introductions to smallpox/mpox disease and the smallpox/mpox vaccine with links to more information. Scroll down for a list of QUICK FACTS that provide a summary overview of key facts for the disease and the vaccine.

The Disease

Smallpox/Monkeypox (Mpox): The Disease

Smallpox is an illness caused by the variola virus, a virus belonging to the orthopoxvirus family of viruses.1 Symptoms of the disease include head and backache, anorexia, severe abdominal pain, vomiting, extreme exhaustion, malaise, chills, rash, and high fever. When the fever resolved, rash lesions would begin to develop and appear in the back of the mouth, behind the oral cavity (oropharynx), followed by the face, arms, and legs, and then would spread to the torso, palms and soles.2 When smallpox was circulating in the environment, there were several forms of the disease, with some more severe and life-threatening than others.3

Monkeypox (mpox) is an infection caused by the mpox virus, which, like the variola virus, is a member of the orthopoxvirus family.4 Symptoms of mpox are similar to smallpox but are generally milder. Individuals infected with mpox usually present with headache, backache, fever, chills, muscle aches, extreme fatigue and exhaustion. Swelling of the lymph nodes also occurs, which is a symptom not present with smallpox infection.5 A rash, which usually appears on the face, begins within one to three days of fever and spreads throughout the body.6 Mpox is rare and is generally found in Africa, although cases and outbreaks have occurred globally.7

The Vaccine

Smallpox/Monkeypox (Mpox): The Vaccine

There are two smallpox vaccines approved by the U.S. Food and Drug Administration (FDA): ACAM2000, a live smallpox (vaccinia) vaccine, and JYNNEOS, a live, non-replicating, smallpox and monkeypox (mpox) vaccine. A third vaccine, Aventis Pasteur Smallpox Vaccine (APSV), is an unapproved vaccine that has been added to the Strategic National Stockpile (SNS).8

Quick Facts

Smallpox/Mpox at a glance

Smallpox/Mpox Disease Quick Facts

  1. Smallpox is an illness caused by the variola virus, belonging to the orthopoxvirus family. There are several forms of smallpox illness, including variola major, modified-type smallpox, hemorrhagic smallpox, malignant (flat-type) smallpox, and variola minor. Variola major was the most common form of the illness when smallpox was circulating in the environment.9 Initial symptoms of smallpox illness included anorexia, vomiting, malaise, high fever, chills, headache, backache, severe abdominal pain, pharyngitis, and extreme exhaustion. A rash might have also been visible in light-skinned individuals. Rash lesions would begin after the fever resolved and appear in the back of the mouth, behind the oral cavity (oropharynx), followed by the face, arms, and legs, and would eventually spread to the torso, palms, and soles.10
  2. Monkeypox (mpox), another orthopoxvirus, is similar in symptoms to smallpox but generally milder. With mpox, infected individuals develop swelling of the lymph nodes.11

Smallpox/Monkeypox Vaccine Quick Facts

  1. There are two smallpox vaccines approved by the U.S. Food and Drug Administration (FDA). The ACAM2000 vaccine is a live smallpox (vaccinia) vaccine approved for use in persons considered at high risk for smallpox infection.12 The JYNNEOS vaccine is a live, non-replicating, smallpox and monkeypox (mpox) vaccine approved for use in adults 18 years of age and older who are considered to be at high risk of smallpox or mpox.13 The FDA has also issued an Emergency Use Authorization (EUA) for the use of the JYNNEOS vaccine to be given subcutaneously to high-risk persons under the age of 18, and intradermally (between the skin layers) to high-risk persons aged 18 and older.1415
  2. Serious adverse events reported following ACAM2000 vaccination include encephalitis (brain inflammation), encephalomyelitis (inflammation of brain and spinal cord), encephalopathy (disease of brain causing alteration of brain function or structure), generalized vaccinia (systemic spread of the virus from the inoculation site), progressive vaccinia (vaccinia necrosum – death of bodily tissues), severe vaccinial skin infections, eczema vaccinatum, erythema multiforme major including Stevens-Johnson syndrome (severe and potentially life-threatening skin and/or mucous membrane lesions), blindness, and fetal death in pregnant women. These complications have the potential to cause severe disability, permanent neurological deficits, and death.16 Serious adverse events reported during clinical trials for the JYNNEOS vaccine noted in the product insert include Crohn’s disease, sarcoidosis (inflammatory disease affecting organs), extraocular muscle paresis (weakening of eye muscles) and throat tightness.17

IMPORTANT NOTE: NVIC encourages you to become fully informed about smallpox/monkeypox (mpox) and the smallpox/monkeypox (mpox) vaccine by reading all sections in the Table of Contents. NVIC provides highly referenced information that allows the public to click through to the reference material used to compile this information, such as the manufacturer product information inserts maintained on the U.S. Food & Drug Administration’s website and vaccine information statements issued by the U.S. Centers for Disease Control and Prevention. As you consider vaccination, we encourage you to educate yourself on the disease and vaccine and to speak with one or more trusted health care professionals before making a vaccination decision for yourself or your child. This information is for educational purposes only and is not intended as medical advice.

References
  1. 1Babkin IV, Babkina IN. The origin of the variola virus. Viruses. Mar. 2015; 7(3):1100-12.
  2. 2US Centers for Disease Control and Prevention. Clinical Disease. Dec. 5, 2016.
  3. 3Babkin IV, Babkina IN. The origin of the variola virus. Viruses. Mar. 2015; 7(3):1100-12.
  4. 4US Centers for Disease Control and Prevention. About Mpox. Aug. 30, 2023.
  5. 5US Centers for Disease Control and Prevention. Signs and Symptoms. Aug. 31, 2023.
  6. 6US Centers for Disease Control and Prevention. Signs and Symptoms. Aug. 31, 2023.
  7. 7US Centers for Disease Control and Prevention. About Mpox. Aug. 30, 2023.
  8. 8US Centers for Disease Control and Prevention. Vaccines. Aug. 8, 2022.
  9. 9US Food and Drug Administration. Smallpox. Mar. 23, 2018.
  10. 10US Centers for Disease Control and Prevention. Clinical Disease. Dec. 5, 2016.
  11. 11US Centers for Disease Control and Prevention. Signs and Symptoms. Aug. 31, 2023.
  12. 12Emergent Product Development Gaithersburg, Inc. ACAM2000. U.S. Food and Drug Administration. Dec. 13, 2019.
  13. 13Bavarian Nordic. JYNNEOS. U.S. Food and Drug Administration. Oct. 2, 2023.
  14. 14US Food and Drug Administration. Monkeypox Update: FDA Authorizes Emergency Use of JYNNEOS Vaccine to Increase Vaccine Supply. Aug. 9, 2022.
  15. 15US Food and Drug Administration. Fact Sheet for Healthcare Providers Administering Vaccine: Emergency Use Authorization of Jynneos (Smallpox and Monkeypox Vaccine, live, Non-replicating) For Prevention of Monkeypox Disease in individuals determined to be at High Risk for Monkeypox Infection. Aug. 16, 2022.
  16. 16Emergent Product Development Gaithersburg, Inc. ACAM2000 – Package Insert. U.S. Food and Drug Administration. Dec. 13, 2019.
  17. 17Bavarian Nordic A/S. Package Insert – JYNNEOS. U.S. Food and Drug Administration. Oct. 2, 2023.
Select disease / vaccine